Avantor, Inc. (NYSE:AVTR) Short Interest Update

Avantor, Inc. (NYSE:AVTR) was the target of a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 29,570,000 shares, an increase of 20.6% from the December 15th total of 24,520,000 shares. Based on an average daily trading volume, of 5,720,000 shares, the short-interest ratio is presently 5.2 days.

Institutional Trading of Avantor

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. MassMutual Private Wealth & Trust FSB boosted its stake in Avantor by 99.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock worth $26,000 after purchasing an additional 625 shares during the period. UMB Bank n.a. purchased a new position in shares of Avantor in the third quarter worth $49,000. Nisa Investment Advisors LLC boosted its position in shares of Avantor by 69.6% during the third quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock worth $53,000 after acquiring an additional 835 shares during the last quarter. GAMMA Investing LLC grew its stake in Avantor by 89.9% during the third quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock valued at $70,000 after acquiring an additional 1,285 shares in the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt increased its holdings in Avantor by 278.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 5,031 shares of the company’s stock valued at $130,000 after acquiring an additional 3,700 shares during the last quarter. Institutional investors own 95.08% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently commented on AVTR shares. Robert W. Baird reduced their price objective on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research report on Monday, October 28th. UBS Group reiterated a “neutral” rating and issued a $25.00 price objective (down previously from $29.00) on shares of Avantor in a research note on Friday. Barclays dropped their price objective on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a report on Friday, October 25th. Wells Fargo & Company reduced their target price on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a report on Monday, October 28th. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $34.00 price target on shares of Avantor in a research note on Thursday, September 26th. Three equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $27.38.

Avantor Price Performance

NYSE:AVTR opened at $22.14 on Friday. The business’s 50-day simple moving average is $21.45 and its two-hundred day simple moving average is $23.35. Avantor has a 52 week low of $19.59 and a 52 week high of $28.00. The stock has a market cap of $15.07 billion, a PE ratio of 48.13, a P/E/G ratio of 3.42 and a beta of 1.28. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.